Yes, you can administer Dihexa daily in research settings, but optimal dosing frequency depends on the compound's estimated half-life of 24 hours, application route, study endpoints, and whether continuous receptor activation or pulsed stimulation better serves the research model
In preclinical assays, BPC-157 accelerates wound closure, supports blood-vessel formation, and protects the gut mucosawithout any systemic growth-hormone activity
(2008b)
Thus, regardless of particularities in angiogenic response(s), different tissues and different healing stage, a more generalized and more powerful angiogenic response induced by BPC 157, with adequately improved angiogenesis leads consistently to better healing conditions and thereby eventually to more adequate healing
Studies highlight its applications in metabolic research, weight management studies, and insulin sensitivity research
Gupta, S., Bansal, R., Sodhi, S., Brar, G., & Malhotra, M